Note: Ingredients listed on restricted chemical lists
EC/CAS
123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
≥10-≤25
EC/CAS
106-97-8
Name of the chemical
n-Butan, enthält 0,1% Butadien
Concentration
≥10-≤25
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≤10
EC/CAS
96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
≤0.3
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
≤0.3
General Information
Version
20
Revision date
2026-03-12
Product name
Valspar Bonding Primer Aero
Manufacturer Name
Valspar
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
Valspar
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H317, H319, H336, H351, H360
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
13.9% (oral), 13.9% (dermal), 15.1% (inhalation)
Signal word
Danger
Hazard statements
Extremely flammable aerosol. Pressurized container: may burst if heated. May cause an allergic skin reaction. Causes serious eye irritation. May cause drowsiness or dizziness. Suspected of causing cancer. May damage fertility or the unborn child.
Precautionary statements
General : Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not spray on an open flame or other ignition source. Use only outdoors or in a well-ventilated area. Avoid breathing dust or mist. Wash thoroughly after handling. Do not pierce or burn, even after use.
Response
IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. IF ON SKIN: Wash with plenty of water. If skin irritation or rash occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up. Protect from sunlight. Do not expose to temperatures exceeding 122 °F/50 °C. Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which can cause permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. Please refer to the SDS for additional information. Keep out of reach of children. Keep upright in a cool, dry place. Do not discard empty can in trash compactor.
2.3 Other hazards
DANGER: Rags, steel wool, other waste soaked with this product, and sanding residue may spontaneously catch fire if improperly discarded. Immediately place rags, steel wool, other waste soaked with this product, and sanding residue in a sealed, water-filled, metal container. Dispose of in accordance with local fire regulations. Hazards identified when used : No known significant effects or critical hazards.
2.1 Classification of the substance or mixture
substance or mixture SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION - Category 1B SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 13.9% (oral), 13.9% (dermal), 15.1% (inhalation)